Therapeutic equivalence [Design Issues]

posted by raghu – India, 2011-02-09 11:07 (5606 d 02:35 ago) – Posting: # 6600
Views: 9,086

Dear Mr Kishore,

You can conduct BE study in healthy volunteers if the anticancer drug not shows any cytotoxic or any major health risk for participating healthy subjects.

Therapeutic equivalence study should be conducted in patients.

Regards
Raghu.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
163 visitors (0 registered, 163 guests [including 35 identified bots]).
Forum time: 14:43 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5